Immuneering Corp Quarterly Cost of Revenue in USD from Q2 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Immuneering Corp quarterly/annual Cost of Revenue history and growth rate from Q2 2020 to Q4 2023.
  • Immuneering Corp Cost of Revenue for the quarter ending December 31, 2023 was $0.000.
  • Immuneering Corp Cost of Revenue for the twelve months ending December 31, 2023 was $0.000, a 100% decline year-over-year.
  • Immuneering Corp annual Cost of Revenue for 2023 was $0.000, a 100% decline from 2022.
  • Immuneering Corp annual Cost of Revenue for 2022 was $158K, a 86.3% decline from 2021.
  • Immuneering Corp annual Cost of Revenue for 2021 was $1.15M, a 9.94% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $0 $0 $0 Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 $0 $0 -$19.3K -100% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $19.3K $0 -$47.9K -100% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $67.3K $0 -$90.8K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $158K $0 -$206K -100% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 $364K $19.3K -$200K -91.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $564K $47.9K -$271K -85% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $835K $90.8K -$318K -77.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.15M $206K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 $219K -$95.9K -30.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $319K +$81.5K +34.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $409K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $315K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $237K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.